CRISPR
| 4 min read
Cross-industry collaborations, coupled with technology innovations, could help bring CRISPR therapies to millions of patients with genetic diseases.
| 6 min read
New AI tools promise to speed up and simplify CRISPR experiments, but their real-world impact is still being tested.
| 3 min read
A gene therapy targeting ANTIGPTL3 reduced cholesterol and triglyceride levels simultaneously.
| 4 min read
Greater focus on non-animal testing methods in the UK, a new CRISPR treatment to lower cholesterol, and positive results for a BTK inhibitor in MS led the news this week.
| 3 min read
Ryvu’s ONCO Prime platform uncovers novel molecular vulnerabilities and actionable targets in colorectal and other cancers.
| 4 min read
A gene therapy trial halted after a child’s death, a CRISPR test to detect tuberculosis, a new device for antisense therapies, and more led the news this week.
Available on Demand
Discover how coculture models and CRISPR tools reveal new insights into tumour microenvironments.
| 4 min read
Vertex-Enlaza autoimmune drugs, DNA-wrapped CRISPR, HHS staff demand Kennedy’s resignation, and more lead the news this week.
| 4 min read
A new CRISPR center for kids, Trump threatens 200 percent tariffs on foreign-made drugs, the first malaria treatment for babies, and more led this week’s news.
| 7 min read
Optimizing CRISPR delivery is essential to unlocking its full potential in drug discovery, enabling efficient, precise, and reproducible gene editing across diverse cell types and experimental contexts.
